SIGA
SIGA Technologies Inc
Halal Rating :
See Details
Last Price
$5.93
Last updated:
Market Cap
$515.29m
7D Change
-21.66%
1 Year Change
16.05%
Company Overview
Industries
Exchange
Nasdaq
Next Earnings Date
SIGA Technologies, Inc. focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $10.01m | $9.47m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $21.81m | $20.73m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $25.43m | $14.15m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate SIGA Technologies Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.